| Name | Apria Healthcare Inc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 2400 Pierce St, Sioux City, Iowa 51104 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (712) 255-1555 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.
Oncobiologics announced today that it has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based large pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies.
Two Dartmouth health policy experts criticize the national breast cancer charity for using misleading statistics to promote breast cancer screening.
Researchers at Oregon Health &Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child. The research, which was led by researchers at OHSU's Oregon National Primate Research Center, will be published in the October 3rd online edition of the journal Nature Medicine.
› Verified 9 days ago
| NPI Number | 1639289226 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2400 Pierce St, Sioux City, IA 51104 |
| Phone Number | 712-255-1555 |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.
Oncobiologics announced today that it has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based large pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies.
Two Dartmouth health policy experts criticize the national breast cancer charity for using misleading statistics to promote breast cancer screening.
Researchers at Oregon Health &Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child. The research, which was led by researchers at OHSU's Oregon National Primate Research Center, will be published in the October 3rd online edition of the journal Nature Medicine.
› Verified 9 days ago
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation.
Oncobiologics announced today that it has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based large pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies.
Two Dartmouth health policy experts criticize the national breast cancer charity for using misleading statistics to promote breast cancer screening.
Researchers at Oregon Health &Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child. The research, which was led by researchers at OHSU's Oregon National Primate Research Center, will be published in the October 3rd online edition of the journal Nature Medicine.
› Verified 9 days ago
Apria Healthcare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2400 Pierce St, Sioux City, Iowa 51104 Phone: (712) 255-1555 | |
Cvs Pharmacy #16923 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5775 Sunnybrook Dr, Sioux City, Iowa 51106 Phone: (712) 274-8854 | |
Valuemed Pharmacy Type: Long Term Care Pharmacy Location: 2442 Transit Ave, Sioux City, Iowa 51106 Phone: (712) 224-4040 | |
Walgreens #5470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4650 Morningside Ave, Sioux City, Iowa 51106 Phone: (712) 276-7744 | |
Wal-mart Pharmacy 10-1361 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3400 Singing Hills Blvd, Sioux City, Iowa 51106 Phone: (712) 252-4905 |